Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of this study is to obtain information on the pharmacokinetics of tacrolimus when used in combination with everolimus in stable kidney transplant patients.
Inclusion criteria
- Stable, adult kidney transplant recipients (≥ 6 months post transplant) who are currently treated with Prograf®/MMF(CellCept®) or Prograf®/Mycophenolate Sodium(Myfortic®) with or without steroids will be enrolled